VivoSeq
Other

Propranolol

0

Pipeline Programs

5

Active Trials

6

Companies Involved

Propranolol is an early-stage landscape with 0 programs across 6 companies. The most active players are Boehringer Ingelheim, Mylan Pharmaceuticals Inc, Par Pharmaceutical, Inc..

Pipeline Metrics

Competitive Density

19/100

Pipeline Velocity

15/100

Mech. Concentration

N/A

Completion Rate

73/100

Attrition Rate

17/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

52

clinical trials

Completed24 · 46%
Unknown status14 · 27%
Terminated6 · 12%
Recruiting3 · 6%
Withdrawn3 · 6%
Enrolling by invitation1 · 2%
Other1 · 2%

Trial Activity

52 trials

Propranolol for Misophonia
Recruiting·BBloom Mental Health, LLC·Phase 1·NCT07271485·20 enrolled
Propranolol Treatment for Postoperative Chylothorax
Recruiting··Phase 1/2·NCT06833320·50 enrolled
Does Propranolol, a Beta Blocker, Attenuate Stress-Induced Drinking?
Active, not recruiting·YYale University·Phase 2·NCT03588754·20 enrolled
Influence of Propranolol on Conditioned Pain Modulation
Completed··N/A·NCT02808611·25 enrolled
Page 1 of 4

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)